Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin. - Test2 - elhamkhani - TriplyDB

Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin.

Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin.

http://www.wikidata.org/entity/Q35831626

about

The Vermont diabetes information system: a cluster randomized trial of a population based decision support system Features of the Chronic Care Model (CCM) associated with behavioral counseling and diabetes care in community primary care Differential effects of comorbidity on antihypertensive and glucose-regulating treatment in diabetes mellitus--a cohort study The longitudinal association between depressive symptoms and initiation of insulin therapy in people with type 2 diabetes in primary care Physician perception of blood pressure control and treatment behavior in high-risk hypertensive patients: a cross-sectional study Variations in coronary artery disease secondary prevention prescriptions among outpatient cardiology practices: insights from the NCDR (National Cardiovascular Data Registry).The quality of care for adults with epilepsy: an initial glimpse using the QUIET measure Safety during the monitoring of diabetic patients: trial teaching course on health professionals and diabetics - SEGUDIAB study.Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study.Comparing methods of measuring treatment intensification in hypertension care Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification?Electronic problem list documentation of chronic kidney disease and quality of care Influence of comorbidities on therapeutic progression of diabetes treatment in Australian veterans: a cohort study Patient-provider concordance in the prioritization of health conditions among hypertensive diabetes patients Participatory decision making, patient activation, medication adherence, and intermediate clinical outcomes in type 2 diabetes: a STARNet study.Impact of clinical complexity on the quality of diabetes care.Drug titration patterns and HbA 1c levels in type 2 diabetes.Diabetes oral medication initiation and intensification: patient views compared with current treatment guidelines.The "cost" of treating to target: cross-sectional analysis of patients with poorly controlled type 2 diabetes in Australian general practice Comorbidity and glycemia control among patients with type 2 diabetes in primary care Clinical inertia in individualising care for diabetes: is there time to do more in type 2 diabetes?Primary language, income and the intensification of anti-glycemic medications in managed care: the (TRIAD) study.So much to do, so little time: care for the socially disadvantaged and the 15-minute visit The effect of incident cancer, depression and pulmonary disease exacerbations on type 2 diabetes control.Diabetes performance measures: current status and future directions.A novel approach to quality improvement in a safety-net practice: concurrent peer review visits Family physician clinical inertia in glycemic control among patients with type 2 diabetes Provider beliefs about diabetes treatment have little impact on glycemic control of their patients with diabetes Management of chronic pain among older patients: inside primary care in the US.Diagnosis and treatment of incident hypertension among patients with diabetes: a U.S. multi-disciplinary group practice observational study Treatment adjustment and medication adherence for complex patients with diabetes, heart disease, and depression: a randomized controlled trial.A cluster randomised controlled trial of the clinical and cost-effectiveness of a 'whole systems' model of self-management support for the management of long- term conditions in primary care: trial protocol.Nephrology co-management versus primary care solo management for early chronic kidney disease: a retrospective cross-sectional analysis.Health coaching to improve hypertension treatment in a low-income, minority population.Does diabetes care differ by type of chronic comorbidity?: An evaluation of the Piette and Kerr framework The importance of relational coordination and reciprocal learning for chronic illness care within primary care teams.Skills-based residency training in alcohol screening and brief intervention: results from the Georgia-Texas "Improving Brief Intervention" Project.Cost-effectiveness of an electronic medical record based clinical decision support system.No moment wasted: the primary-care visit for adults with diabetes and low socio-economic status.Implementing change in primary care practices using electronic medical records: a conceptual framework.

P2860

Q24646428-5812FD2D-EE2E-479E-800C-F585E5A40A59 Q28382881-14834FB6-6FE6-41D8-A419-4B989A1356F2 Q28484110-940858CF-9308-46CD-8EBB-A5BB67B7EBF3 Q28534790-5C6D389C-C909-4D32-8736-09251765D6C9 Q28740395-2B01B3E1-4EBC-4451-B703-893E2E78A023 Q30687917-613C6228-AA91-467F-A47E-34362ED05316 Q30993847-BD063A6C-32EC-4F21-80A6-231C6858BC59 Q31016161-95806296-5D6C-459F-A811-C4A812C3DCA3 Q33433176-959F09EA-9531-4529-9106-94F26E4F6BD2 Q33572437-99FD327E-FAE6-4386-A42A-99BF143A1E33 Q33606011-2B98D75B-524E-4AAD-B941-9640DB27855A Q33613413-CFF3C31A-1182-4586-96E1-6F630C28C66A Q33754547-222822EA-675B-4E09-9051-0BAFFD6676DB Q33790975-EC7C995F-71E7-41DA-AC18-44CEE17A8165 Q34127664-3828E6AC-A805-49B9-9B01-81461F3EFE64 Q34223014-E37289FB-5B56-411D-A81E-F2A0785E7A89 Q34322132-EF15FC2F-3BDB-476C-95AB-38C96C228138 Q34553412-E95A506C-DCB0-453B-BC9A-CCDA77CDD6BC Q34627590-95E5FD04-D38B-4766-972F-C88CBAF27132 Q34642537-20FE63A5-EA05-4E89-B982-1D17DB418F6A Q34726295-86055616-7819-4BEB-8E23-BA1F5641D7D8 Q34799014-CE07BA9C-B2BC-4309-A0A7-835B323FBAB3 Q34834185-4B11317C-264A-4504-AC85-FA6BCB4982FB Q35007047-E637715F-5149-43DF-844C-91945A984B24 Q35060223-754A2345-F529-4628-816C-CB42E73A3F16 Q35070277-DF158547-C1FF-45B3-B032-D003F0EBF9D6 Q35087628-6FC1D1E7-05AE-44DD-A25C-FFE29C43FCD3 Q35126777-4AD7B933-5F14-4DB9-840A-2B42A340DB6C Q35529166-41249697-40D5-4B2E-A726-21FDBBBE7400 Q35638232-E5A7FC38-D51C-490C-93EC-DF7B8423CCF7 Q35684156-3390DE5F-F505-44B2-AC34-03726324C909 Q35742252-2C45DB71-DE7C-4A97-BFDE-0AB6EC4164AE Q35803618-3212BBA6-2571-4993-9B4C-D1279E2F45D6 Q35968188-08C37C77-B6D4-46E0-A826-3CBFD628202B Q35976407-9DD26DB3-6E14-40F2-BEE0-463E02030E22 Q36060502-0163D7EC-B12E-4B37-B4D9-97DF45873A57 Q36198131-9110434C-8C69-4403-AF59-D51AEEA35EBE Q36282573-CCBBE749-EF0D-42D7-A692-0B051D8AE0C1 Q36419516-31CA7218-7F2E-4539-910F-E23A12137F9A Q36478729-46E3703F-A23B-4DB6-97DA-83849247EE54

P2860

Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin.

http://www.wikidata.org/entity/Q35831626

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin.

@ast

Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin.

@en

type

label

Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin.

@ast

Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin.

@en

prefLabel

Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin.

@ast

Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin.

@en

P1433

Q35831626-D24BBECA-795A-46DB-9AD8-716569696904

P1476

Q35831626-7B26EF68-3700-4AAA-846E-6DD1D429EE9B

P2093

Q35831626-1539790F-3E35-4519-9028-55E7B97A8462

Q35831626-18E4AF2C-82AE-43EB-9A92-E1403F78A2CD

Q35831626-558AB291-9318-448D-AA04-28C3ABD59252

Q35831626-FF4461C9-59D7-44C8-818C-323C6F827059

P2860

Q35831626-0B727C57-6E3A-404C-94C5-481ACC41F8CF

Q35831626-1CA335FC-CF2D-42CB-8BFD-CA7ADE7F1A16

Q35831626-299064D6-DF1E-4FCA-B0A5-52DDE6165267

Q35831626-2B262368-FE12-4D5A-B7FE-D9C389C2F8F8

Q35831626-42E12BA9-0185-42C8-B345-D2A0B5E57201

Q35831626-43BE5113-C437-4043-A9AD-112F15D65615

Q35831626-5F38A6E5-40B8-4900-8904-A44C4AA28BA3

Q35831626-7021C8C9-CB29-48A2-A44A-3874A2994C5B

Q35831626-8D078758-5D33-4167-85B4-2982A8C26CBA

Q35831626-B82D8A8E-D3DF-4487-89B6-9AF370CE9E3C

P304

Q35831626-E39C06BC-3E56-47CB-8FB1-457936FFAA65

P31

Q35831626-B20A1BF5-9F40-4FB6-A57D-69B005493AD2

P356

Q35831626-FCFBEDE1-817A-4D96-B481-0C1290902CD6

P407

Q35831626-0A3C1EDC-CA60-4B09-B177-B63E55AE791C

P433

Q35831626-C83CD412-03AE-411B-8D40-065D89B2F4A2

P478

Q35831626-ABF51907-5B5A-455F-88B9-BA6EE2CC1480

P577

Q35831626-B4A7E4A5-10D6-492A-9BA8-FFDB828E0BE5

P5875

Q35831626-97E31DB2-16A8-4378-AB2A-FB9C0CDA8476

P698

Q35831626-8CC54E71-2DAF-4B34-BC99-FBBCAF12DA6D

P921

Q35831626-7318C653-F150-4233-96B5-9DECAEEB9164

P932

Q35831626-A730D1D2-5468-4C7A-B674-247496249318

P356

P1433

Annals of Family Medicine

P1476

Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin.

@en

P2093

Jacqueline A Pugh

http://www.w3.org/2001/XMLSchema#string

Krista W Bowers

http://www.w3.org/2001/XMLSchema#string

Michael L Parchman

http://www.w3.org/2001/XMLSchema#string

Raquel L Romero

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Prevalence of patients with type 2 diabetes mellitus reaching the American Diabetes Association's target guidelines in a university primary care setting

Developing a quality measure for clinical inertia in diabetes care.

Clinical inertia.

The treatment of unrelated disorders in patients with chronic medical diseases.

Is there time for management of patients with chronic diseases in primary care?

Encounters by patients with type 2 diabetes--complex and demanding: an observational study.

When there is too much to do: how practicing physicians prioritize among recommended interventions.

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.

Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus.

P304

196-201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1370/AFM.679

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6287486

http://www.w3.org/2001/XMLSchema#string

P698

17548846

http://www.w3.org/2001/XMLSchema#string

P921

P932

1886492

http://www.w3.org/2001/XMLSchema#string